GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Traditional Chinese Medicine Holdings Co Ltd (HKSE:00570) » Definitions » Research & Development

China Traditional Chinese Medicine Holdings Co (HKSE:00570) Research & Development : HK$750 Mil (TTM As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is China Traditional Chinese Medicine Holdings Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. China Traditional Chinese Medicine Holdings Co's Research & Development for the six months ended in Dec. 2023 was HK$407 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was HK$750 Mil.


China Traditional Chinese Medicine Holdings Co Research & Development Historical Data

The historical data trend for China Traditional Chinese Medicine Holdings Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Traditional Chinese Medicine Holdings Co Research & Development Chart

China Traditional Chinese Medicine Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 516.31 652.55 850.32 683.24 749.93

China Traditional Chinese Medicine Holdings Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 489.47 372.21 328.65 343.03 406.91

China Traditional Chinese Medicine Holdings Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$750 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Traditional Chinese Medicine Holdings Co  (HKSE:00570) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


China Traditional Chinese Medicine Holdings Co Research & Development Related Terms

Thank you for viewing the detailed overview of China Traditional Chinese Medicine Holdings Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


China Traditional Chinese Medicine Holdings Co (HKSE:00570) Business Description

Traded in Other Exchanges
Address
288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through five segments, finished drugs; concentrated TCM granules; TCM decoction pieces; TCM healthcare complex, and Local TCM integrated operation. It generates maximum revenue from the concentrated TCM granules segment. Geographically, it derives a majority of its revenue from Mainland China.

China Traditional Chinese Medicine Holdings Co (HKSE:00570) Headlines

No Headlines